[Treatment of mitral MRSA endocarditis using daptomycin].
Senneville
E
E
Service Universitaire Régional des Maladies Infectieuses et du Voyageur, Hôpital Gustave Dron, 59200 Tourcoing, France.
Beltrand
E
E
Legout
L
L
Leroy
O
O
Fayad
G
G
D000368:Aged; D000900:Anti-Bacterial Agents / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D016470:Bacteremia / Q000188:drug therapy / Q000382:microbiology; D003131:Combined Modality Therapy; D017576:Daptomycin / Q000494:pharmacology / Q000627:therapeutic use*; D020878:Device Removal; D004359:Drug Therapy, Combination; D004697:Endocarditis, Bacterial / Q000188:drug therapy* / Q000382:microbiology / Q000601:surgery; D017809:Fatal Outcome; D005260:Female; D005839:Gentamicins / Q000008:administration & dosage / Q000627:therapeutic use; D006622:Hip Prosthesis / Q000009:adverse effects*; D006801:Humans; D055624:Methicillin-Resistant Staphylococcus aureus / Q000187:drug effects* / Q000302:isolation & purification; D008943:Mitral Valve / Q000382:microbiology* / Q000473:pathology / Q000601:surgery; D011183:Postoperative Complications / Q000209:etiology; D016459:Prosthesis-Related Infections / Q000188:drug therapy* / Q000382:microbiology / Q000601:surgery; D012128:Respiratory Distress Syndrome / Q000209:etiology; D012293:Rifampin / Q000008:administration & dosage / Q000627:therapeutic use; D013203:Staphylococcal Infections / Q000188:drug therapy* / Q000382:microbiology / Q000601:surgery; D013921:Thrombocytopenia / Q000139:chemically induced; D014640:Vancomycin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D005839:Gentamicins; D014640:Vancomycin; D017576:Daptomycin; D012293:Rifampin